Perimeter Advances AI Breast Cancer Surgery With Claire
Toronto, Canada and Dallas, Texas, August 13, 2026 Perimeter Medical Imaging AI Inc. has announced that Intermountain Health has...
Breast Cancer Treatment
Advertisement
IceCure Highlights Cryoablation Advances in Breast Cancer Care
Caesarea, Israel, August 13, 2026 IceCure Medical Ltd., a developer of minimally invasive cryoablation technology for tumor treatment, has...
Biocon Secures Health Canada Approval for Yesintek Pen
BENGALURU, Karnataka, India, July 29, 2026 Biocon Limited has announced that its Canadian subsidiary has received Health Canada Notice...
IceCure Seeks NCCN Support for Breast Cancer Cryoablation
CAESAREA, Israel, July 29, 2026 IceCure Medical Ltd. has announced a significant development that could broaden the role of...
Delphi Diagnostics Validates EAI for Paclitaxel Benefit
HOUSTON, Texas, June 22, 2026 Delphi Diagnostics has announced the publication of new clinical findings validating the predictive power...
Advertisements
Datroway by AstraZeneca Approved as First TROP2 ADC for TNBC
Cambridge, United Kingdom – May 22, 2026 AstraZeneca and Daiichi Sankyo announced that the U.S. Food and Drug Administration...
Henlius and Organon Secure EU Approval for POHERDY®
SHANGHAI, China & JERSEY CITY, N.J., April 29, 2026 Shanghai Henlius Biotech, Inc. and Organon have announced that the...
Celcuity Reports Phase 3 Gedatolisib Results in Breast Cancer
Minneapolis, USA – March 9, 2026 Celcuity Inc. has announced the publication of positive Phase 3 VIKTORIA-1 clinical trial...
ASBrS Recommends Cryoablation for Low-Risk Breast Cancer
Caesarea, Israel – March 9, 2026 A newly updated 2026 Resource Guide from the American Society of Breast Surgeons...
IceCure Wins Israel Approval for XSense™ Cryoablation System
CAESAREA, Israel, Sept. 15, 2025 – IceCure Medical Ltd. (NASDAQ: ICCM), a pioneer in minimally invasive cryoablation therapies, today...
Advertisement
